Quantities
| P2899 | minimum age | 18 |
| P1132 | number of participants | 542 |
| P6099 | clinical trial phase | ... | Q42824827 (phase III clinical trial) | phase III clinical trial |
| P17 | country | ... | Q16 (Canada) | Canada |
| P17 | country | ... | Q28 (Hungary) | Hungary |
| P17 | country | ... | Q30 (United States) | United States |
| P17 | country | ... | Q34 (Sweden) | Sweden |
| P17 | country | ... | Q35 (Denmark) | Denmark |
| P17 | country | ... | Q36 (Poland) | Poland |
| P17 | country | ... | Q183 (Germany) | Germany |
| P17 | country | ... | Q218 (Romania) | Romania |
| P17 | country | ... | Q219 (Bulgaria) | Bulgaria |
| P17 | country | ... | Q224 (Croatia) | Croatia |
| P17 | country | ... | Q258 (South Africa) | South Africa |
| P582 | end time | ... | 2015-08-01 | ??? |
| P31 | instance of | ... | Q30612 (clinical trial) | clinical trial |
| P131 | located in the administrative territorial entity | ... | Q1183 (Puerto Rico) | Puerto Rico |
| P4844 | research intervention | ... | Q412174 (pregabalin) | pregabalin |
| P6153 | research site | ... | Q4614 (University of Southern California) | University of Southern California |
| P6153 | research site | ... | Q126412 (Massachusetts General Hospital) | Massachusetts General Hospital |
| P6153 | research site | ... | Q4403855 (Seoul National University Hospital) | Seoul National University Hospital |
| P6153 | research site | ... | Q7309746 (Shirley Ryan AbilityLab) | Shirley Ryan AbilityLab |
| P6153 | research site | ... | Q30269522 (Atlanta Center for Medical Research) | Atlanta Center for Medical Research |
| P6153 | research site | ... | Q30269704 (Meridien Research) | Meridien Research |
| P6153 | research site | ... | Q30269718 (Compass Research) | Compass Research |
| P6153 | research site | ... | Q30269845 (Diablo Clinical Research) | Diablo Clinical Research |
| P6153 | research site | ... | Q30270033 (PMG Research) | PMG Research |
| P6153 | research site | ... | Q30270436 (Summit Research Network) | Summit Research Network |
| P6153 | research site | ... | Q30282105 (Lynn Health Science Institute) | Lynn Health Science Institute |
| P6153 | research site | ... | Q30282378 (Northwest Clinical Research Center) | Northwest Clinical Research Center |
| P6153 | research site | ... | Q30289162 (Wells Institute for Health Awareness) | Wells Institute for Health Awareness |
| P6153 | research site | ... | Q55670688 (Medex) | Medex |
| P6153 | research site | ... | Q868421 (University of California, Irvine) | University of California, Irvine |
| P580 | start time | ... | 2012-10-01 | ??? |
| P8363 | study type | ... | Q78089383 (interventional study) | interventional study |
| P1476 | title | Monolingualtext | A Randomized Double Blind Placebo Controlled Parallel Group Study Of The Efficacy And Safety Of Pregabalin (Bid) In Subjects With Post-traumatic Peripheral Neuropathic Pain | ??? |
| P3098 | ClinicalTrials.gov ID | NCT01701362 |
Why not click here or view trends?
log id: 4820394